Royal Philips today introduced Vereos PET/CT, the first digital PET/CT scanner, at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging  (SNMMI), taking place this week in St. Louis, Mo.  In addition to Vereos, Philips will showcase a selection of innovative, molecular imaging solutions designed to deliver outstanding image quality, critical clinical information and greater connectivity.

ST. LOUIS--As the weekend opening of the 61st Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting sunsets, three more days full of meetings, presentations and exhibitions approach. See an SNMMI-hosted audiovisual montage of highlights and attendee interviews from the first two days of the conference.

ImaginAb, Inc., in collaboration with Memorial Sloan-Kettering Cancer Center (MKSCC), will be presenting initial clinical data with an anti-PSMA recombinant antibody fragment (a "minibody") derived from the huJ591 monoclonal antibody, in patients with metastatic prostate cancer. The presentation of this initial data coincides with the Company's preparation to expand the clinical development of this promising imaging agent in the US and internationally.

The new cancer center paradigm provides genetic tests not just for experimental research, but as a clinical standard. In this glimpse by Bloomberg, Memorial Sloan Kettering Cancer Center shows off a new laboratory opened just weeks ago where patients' biopsies will be tested for 341 mutations associated with disease.

Bethesda, MD (June 3, 2014) The American Society of Nuclear Cardiology (ASNC) will be offering a Nuclear Cardiology Board Exam Preparation Course from July 11-13 at the Intercontinental Hotel Chicago O'hare in Rosemont, Ill.

The University of Minnesota Medical Center – Fairview Health Services, Minneapolis, recently became the first U.S. health care facility to install the Symbia Intevo xSPECT system from Siemens Healthcare.

A U-SPECT+/CT (MILabs, The Netherlands) will be installed at Northwestern University (Chicago, IL) to deliver ultra-high resolution, high sensitivity, accurate quantification and fast scanning speed of dynamic radio-labeled molecule distributions, contributing to molecular and functional studies in CNS, cardiovascular, oncology, nephrology and reproductive biology.

T cell immunotherapy prompted a striking response from three out of nine women with advanced cervical cancer, including one who had extensive metastases, according to new data from the National Cancer Institute. This could offer an alternative treatment option for women with few choices remaining.